You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


Parkinson Disease/ Parkinsonian Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 1-10 of 360 total displayed.

Most recent content

Arch Neurol
Original Contributions
Clinical Features in Early Parkinson Disease and Survival
Raymond Y. Lo; Caroline M. Tanner; Kathleen B. Albers; Amethyst D. Leimpeter; Robin D. Fross; Allan L. Bernstein; Valerie McGuire; Charles P. Quesenberry; Lorene M. Nelson; Stephen K. Van Den Eeden
Arch Neurol 2009; 66: 1353-1358. [Abstract] [Full text] [Full text PDF]  

Past content

Arch Neurol
Original Contributions
Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
Alberto Ascherio; Peter A. LeWitt; Kui Xu; Shirley Eberly; Arthur Watts; Wayne R. Matson; Connie Marras; Karl Kieburtz; Alice Rudolph; Mikhail B. Bogdanov; Steven R. Schwid; Marsha Tennis; Caroline M. Tanner; M. Flint Beal; Anthony E. Lang; David Oakes; Stanley Fahn; Ira Shoulson; Michael A. Schwarzschild; for the Parkinson Study Group DATATOP Investigators
Arch Neurol 2009.247. [Abstract] [Full text] [PDF] [ eFigure and eTables ]  

Arch Neurol
Original Contributions
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience
Sotirios A. Parashos; Christopher J. Swearingen; Kevin M. Biglan; Ivan Bodis-Wollner; Grace S. Liang; G. Webster Ross; Barbara C. Tilley; Lisa M. Shulman; for the NET-PD Investigators
Arch Neurol 2009; 66: 1099-1104. [Abstract] [Full text] [Full text PDF]  

Arch Neurol
Original Contributions
Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study
Caroline M. Tanner; G. Webster Ross; Sarah A. Jewell; Robert A. Hauser; Joseph Jankovic; Stewart A. Factor; Susan Bressman; Amanda Deligtisch; Connie Marras; Kelly E. Lyons; Grace S. Bhudhikanok; Diana F. Roucoux; Cheryl Meng; Robert D. Abbott; J. William Langston
Arch Neurol 2009; 66: 1106-1113. [Abstract] [Full text] [Full text PDF]  

Arch Neurol
Original Contributions
Comparison of Risk Factor Profiles in Incidental Lewy Body Disease and Parkinson Disease
Roberta Frigerio; Hiroshige Fujishiro; Demetrius M. Maraganore; Kevin J. Klos; Anthony DelleDonne; Michael G. Heckman; Julia E. Crook; Keith A. Josephs; Joseph E. Parisi; Bradley F. Boeve; Dennis W. Dickson; J. Eric Ahlskog
Arch Neurol 2009; 66: 1114-1119. [Abstract] [Full text] [Full text PDF]  

Arch Gen Psychiatry
Original Articles
Reduced {alpha}4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
Philipp M. Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann J. Gertz; Osama Sabri; Johannes Schwarz
Arch Gen Psychiatry 2009; 66: 866-877. [Abstract] [Full text] [Full text PDF] [ eFigures ]  

Arch Neurol
Original Contributions
Determinants of the Timing of Symptomatic Treatment in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience
Sotirios A. Parashos; Christopher J. Swearingen; Kevin M. Biglan; Ivan Bodis-Wollner; Grace S. Liang; G. Webster Ross; Barbara C. Tilley; Lisa M. Shulman; for the NET-PD Investigators
Arch Neurol 2009.159. [Abstract] [Full text] [PDF]  

Arch Neurol
Original Contributions
Elevated Serum Pesticide Levels and Risk of Parkinson Disease
Jason R. Richardson; Stuart L. Shalat; Brian Buckley; Bozena Winnik; Padraig O’Suilleabhain; Ramon Diaz-Arrastia; Joan Reisch; Dwight C. German
Arch Neurol 2009; 66: 870-875. [Abstract] [Full text] [Full text PDF]  

Arch Neurol
Original Contributions
Dysfunction of the Default Mode Network in Parkinson Disease: A Functional Magnetic Resonance Imaging Study
Thilo van Eimeren; Oury Monchi; Benedicte Ballanger; Antonio P. Strafella
Arch Neurol 2009; 66: 877-883. [Abstract] [Full text] [Full text PDF]  

Arch Neurol
Correspondence
Parkinson Disease: Extranigral, Multisystem, and {alpha}-Synuclein "Plus"
Michail E. Kalaitzakis; Manuel B. Graeber; Stephen M. Gentleman; Ronald K. B. Pearce
Arch Neurol 2009; 66: 914-915. [Extract] [Full text] [Full text PDF]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

 Collections
 •Sign up for Topic Collection Alerts
 •Topic Collections Home
 •Related collections:
  •Neurology
  •Alzheimer Disease
  •Amyotrophic Lateral Sclerosis
  •Ataxia
  •Behavioral Neurology
  •Cerebrovascular Disease
  •Cognitive Disorders
  •Coma/ Vegetative State
  •Deep Brain Stimulation
  •Dementias
  •Neuroimaging
  •Encephalitis
  •Epilepsy
  •Functional Imaging
  •Neurogenetics
  •Headache
  •Lewy Body Disease
  •Meningitis
  •Migraine
  •Movement Disorders
  •Multiple Sclerosis/ Demyelinating Disease
  •Myasthenia Gravis
  •Neurocutaneous Diseases
  •Neuroendocrinology
  •Neuromuscular diseases
  •Neuro-otology
  •Neuro-ophthalmology
  •Neuropathology
  •Neurotoxicology
  •Parkinson Disease/ Parkinsonian Disorders
  •Pediatric Neurology
  •Stroke
Advertisement





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.